Page last updated: 2024-08-23

substance p and ramipril

substance p has been researched along with ramipril in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lloyd, GS; Turner, AJ1
Carretero, OA; Curran, CM; Hintze, TH; Laycock, SK; Loke, KE; Messina, EJ; Shesely, EG1
Hintze, TH; Kaley, G; Loke, KE; Messina, EJ; Shesely, EG1
Bessaguet, F; Danigo, A; Demiot, C; Desmoulière, A; Magy, L; Sturtz, F1

Other Studies

4 other study(ies) available for substance p and ramipril

ArticleYear
Aminopeptidase P: cation activation and inhibitor sensitivity are substrate-dependent.
    Biochemical Society transactions, 1995, Volume: 23, Issue:1

    Topics: Amino Acid Sequence; Aminopeptidases; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cilazapril; Enalaprilat; Kidney; Kinetics; Molecular Sequence Data; Oligopeptides; Ramipril; Substance P; Substrate Specificity; Swine

1995
Role of nitric oxide in the control of cardiac oxygen consumption in B(2)-kinin receptor knockout mice.
    Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:4 Pt 1

    Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Calcium Channel Blockers; Drug Interactions; Enzyme Inhibitors; Female; Heart; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxygen Consumption; Ramipril; Receptors, Bradykinin; Substance P

1999
Potential role of eNOS in the therapeutic control of myocardial oxygen consumption by ACE inhibitors and amlodipine.
    Cardiovascular research, 2001, Volume: 49, Issue:1

    Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Carbachol; Cardiotonic Agents; Culture Techniques; Diltiazem; Dose-Response Relationship, Drug; Female; Male; Mice; Mice, Inbred C57BL; Myocardium; Nitric Oxide Donors; Nitric Oxide Synthase; Oxygen Consumption; Ramipril; S-Nitroso-N-Acetylpenicillamine; Substance P; Vasodilator Agents

2001
Candesartan prevents resiniferatoxin-induced sensory small-fiber neuropathy in mice by promoting angiotensin II-mediated AT2 receptor stimulation.
    Neuropharmacology, 2017, Volume: 126

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Calcitonin Gene-Related Peptide; Diterpenes; Ganglia, Spinal; Imidazoles; Male; Mice; Mice, Knockout; Neuroprotective Agents; Pyridines; Ramipril; Receptor, Angiotensin, Type 2; Sensory Receptor Cells; Small Fiber Neuropathy; Substance P; Tetrazoles

2017